Durham biotech firm Xilis, bolstered with $89M, forms advisory board
Following a Series A fundraising round of $89 million, Durham-based biotech company Xilis has formed a scientific advisory board.
Read More
xilis
Durham biotech startup Xilis raises $19M for precision cancer therapy, drug discovery
Biotech startup Xilis has added another $19 million to its round of financing, pushing the total to $89 million from the $70 million announced a year ago. Here are the details.
Read More
Venture Connect preview: Startup CEOs share lessons from raising over $250M
Three high-profile startup CEOs will speak at CED Venture Connect Summit next week in a session called “Growth Stories”. Each CEO will join the stage with one of their investment partners to discuss recent fundraising. But we have a sneak preview of the wisdom they’ve gained and the lessons they’ve learned.
Read More
Durham medtech startup Xilis raises $70M; Google Ventures, Duke Angels among backers
Xilis, a startup founded by two professors at Duke University focusing on technology to boost precision health and oncology, has landed $70 million in new funding with Google Ventures among the backers.
Read More
Chapel Hill startup focusing on precision health, oncology raises additional $1.8M
That brings the total raised to roughly $4.85 since December 2019. Eight investors contributed to the round.
Read More
Chapel Hill startup focusing on precision health, oncology raises $3M
Xilis, a startup founded by two professors at Duke University focusing on precision health and oncology, has closed on $3 million in financing.
Read More
